GlassScriptPhysician profile
Olga Voroshilovsky
NPI 1659402311
$8,339.43
in general payments reported to CMS, 2019-2025
16 companies · $669 in 2025
The $669 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,443 · 2020: $804 · 2021: $1,720 · 2022: $754 · 2023: $1,041 · 2024: $908 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,618.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,647.32 | 2019-2025 | General - Therapies, Mylux Patient Kit With Mobile Device, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $2,757.62 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Novartis Pharmaceuticals Corporation | $307.52 | 2019-2025 | |
| Pfizer INC. | $88.11 | 2023-2024 | |
| Amgen INC. | $81.56 | 2023-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $74.16 | 2023-2024 | Sapien 3 Ultra Resilia |
| Cleerly, INC. | $60.53 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Bayer Healthcare Pharmaceuticals INC. | $46.60 | 2023-2024 | |
| Medtronic Vascular, INC. | $46.42 | 2019-2020 | |
| Lilly USA, LLC | $41.63 | 2023-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $41.36 | 2023-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $39.81 | 2024-2025 | Camzyos |
| Guerbet LLC | $37.30 | 2022 | |
| Dexcom, INC. | $28.69 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $28.62 | 2025 | Wegovy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Voroshilovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.